Clin2
NCT07807371Possibly a fitNot yet recruiting

Timing of tranexamic acid injection in mohs surgery

Healthy

This study looks at the timing of a medicine called tranexamic acid, which is injected under the skin to reduce bleeding and bruising after Mohs surgery for skin cancer. If you are having Mohs surgery with same-day closure, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You are having Mohs surgery (a step-by-step removal of skin cancer) and the wound will be closed with stitches or a skin flap on the same day.
  • You are not allergic to tranexamic acid (a medicine that helps reduce bleeding).
  • You have not had a blood clot, stroke, or heart attack within the last 3 months, and you do not have an active clot or heart problem at the time of surgery.
  • Your blood pressure is not extremely high (above 200 mm Hg systolic) at the time of surgery.
  • You are not pregnant or breastfeeding.
  • You are willing and able to come back for a follow-up check about 48 hours after surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06057675Recruiting· Phase 2
Tranexamic acid for nose reconstruction after Mohs surgery

This trial tests if tranexamic acid (a medicine that helps blood clot) reduces bleeding and bruising during nose reconstruction after skin cancer removal. It is for adults having a specific type of flap repair on their nose.

Nashville, Tennessee
NCT05794321Recruiting· Phase 2
IV tranexamic acid during gender-affirming chest surgery

This Phase 2 study tests whether giving tranexamic acid through a vein during gender-affirming mastectomy can safely reduce bleeding. It may help lower blood loss and related complications during surgery.

San Francisco, California
NCT05899465Recruiting· Phase 3
Tranexamic acid during melanoma surgery to reduce bleeding

This Phase 3 trial tests whether giving tranexamic acid (a medicine that helps reduce bleeding) around the time of surgery can improve outcomes for people with invasive skin melanoma. It may help reduce surgical bleeding while keeping patients safe.

Aarhus, Central Jutland
NCT06618820Enrolling by invitation· Phase 3
Extended tranexamic acid after knee replacement

This trial tests whether taking tranexamic acid (a medicine that helps blood clot) for several days after knee replacement surgery reduces bleeding and improves recovery. It may help patients who have a standard knee replacement and are not on blood thinners.

Germantown, Tennessee
NCT07494032Not yet recruiting
Extended tranexamic acid after total knee replacement

This study tests whether taking tranexamic acid (a medication that helps blood clot) for a few days after knee replacement surgery can reduce bleeding and the need for blood transfusions. It may help patients recover with fewer complications.

New York, New York
NCT05774717Recruiting· Phase 1
Tranexamic acid for bleeding after open nose surgery

This Phase 1 study tests whether tranexamic acid (a medicine that helps reduce bleeding) can lessen bleeding, swelling, and bruising after open rhinoplasty. You may be asked to take it around the time of surgery if you meet safety and lab criteria.

Nashville, Tennessee

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.